Kathleen D. Scott, Chief Financial Officer at ARS Pharmaceuticals, Inc. (SPRY), bought 8,250 shares at $6.24 ($51K) on 2022-11-29, disclosed to the SEC on 2022-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SPRY | SELL | 2025-05-22 | $705K | — | Filing → |
| SPRY | SELL | 2024-10-17 | $200K | — | Filing → |
| SPRY | SELL | 2024-08-21 | $200K | — | Filing → |